BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2231060)

  • 1. Colorectal cancer: have we identified an effective screening strategy?
    Friedman GD; Selby JV
    J Gen Intern Med; 1990; 5(5 Suppl):S23-7. PubMed ID: 2231060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening in asymptomatic populations.
    Hart AR; Wicks AC; Mayberry JF
    Gut; 1995 Apr; 36(4):590-8. PubMed ID: 7737570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer. Use of a new protocol may reduce death rates.
    Lush DT
    Postgrad Med; 1994 Jul; 96(1):99-106. PubMed ID: 8022720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening sigmoidoscopy and colorectal cancer mortality.
    Newcomb PA; Norfleet RG; Storer BE; Surawicz TS; Marcus PM
    J Natl Cancer Inst; 1992 Oct; 84(20):1572-5. PubMed ID: 1404450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
    Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
    Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
    Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
    Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of distal polyps detected with flexible sigmoidoscopy in asymptomatic patients.
    Matter SE; Campbell DR
    Arch Intern Med; 1992 Sep; 152(9):1776-80. PubMed ID: 1520044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer--now and the near future.
    Bromer MQ; Weinberg DS
    Semin Oncol; 2005 Feb; 32(1):3-10. PubMed ID: 15726501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in colorectal cancer screening and prevention.
    Pignone M; Levin B
    Am Fam Physician; 2002 Jul; 66(2):297-302. PubMed ID: 12152966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative.
    Richardson JL; Danley K; Mondrus GT; Deapen D; Mack T
    Prev Med; 1995 Mar; 24(2):166-70. PubMed ID: 7597019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.